The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia-A Randomized and Double-Blinded Study

Abstract

The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia-A Randomized and Double-Blinded Study Huang YS, Tang I, Chin WC, Jang LS, Lee CP, Lin C, Yang CP, Cho SL. The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia-A Randomized and Double-Blinded Study. Nat Sci Sleep. 2022 Jun 8;14:1113-1124. doi: 10.2147/NSS.S346941. Abstract Purpose: Accumulated studies revealed that electromagnetic field can affect human brain and sleep, and the extremely low-frequency electromagnetic field, Schumann resonance, may have the potential to reduce insomnia symptoms. The purpose of this study was to investigate the responses of patients with insomnia to a non-invasive treatment, Schumann resonance (SR), and to evaluate its effectiveness by subjective and objective sleep assessments. Patients and methods: We adopted a double-blinded and randomized design and 40 participants (70% female; 50.00 ± 13.38 year) with insomnia completed the entire study. These participants were divided into the SR- sleep-device group and the placebo-device group and were followed up for four weeks. The study used polysomnography (PSG) to measure objective sleep and used sleep diaries, Pittsburgh Sleep Quality Inventory (PSQI), Epworth Sleepiness Scale (ESS), and visual analogy of sleep satisfaction to measure subjective sleep. The 36-Item Short-Form Health Survey (SF-36) was used to evaluate quality of life. Chi-square test, Mann-Whitney U- test, and Wilcoxon test were used to analyze the data. Results: About 70% of the subjects were women, with an average age of 50±13.38 years and an average history of insomnia of 9.68±8.86 years. We found that in the SR-sleep-device group, objective sleep measurements (sleep-onset-latency, SOL, and total-sleep-time, TST) and subjective sleep questionnaires (SOL, TST, sleep- efficiency, sleep-quality, daytime-sleepiness, and sleep-satisfaction) were significantly improved after using the SR-sleep-device; in the placebo-device group, only such subjective sleep improvements as PSQI and sleep- satisfaction were observed. Conclusion: This study demonstrates that the SR-sleep-device can reduce the insomnia symptoms through both objective and subjective tests, with minimal adverse effects. Future studies can explore the possible mechanism of SR and health effects and, with a longer tracking time, verify the effectiveness and side effects. Open access paper: ncbi.nlm.nih.gov

AI evidence extraction

Main findings

In the Schumann resonance (SR) sleep-device group, objective sleep measures (SOL and TST) and multiple subjective sleep measures (including SOL, TST, sleep efficiency, sleep quality, daytime sleepiness, and sleep satisfaction) significantly improved after use. In the placebo-device group, only subjective improvements (PSQI and sleep satisfaction) were observed.

Outcomes measured

• Objective sleep (polysomnography): sleep-onset latency (SOL), total sleep time (TST)
• Subjective sleep: sleep diaries, Pittsburgh Sleep Quality Inventory (PSQI), Epworth Sleepiness Scale (ESS), visual analogy of sleep satisfaction
• Quality of life: SF-36
• Sleep efficiency
• Sleep quality
• Daytime sleepiness
• Sleep satisfaction

Limitations

• Frequency/exposure parameters for the SR device not reported in the abstract
• Follow-up duration limited to four weeks
• Sample size relatively small (n=40)

Suggested hubs

• sleep-and-emf (0.9)
  Randomized double-blind trial of ELF (Schumann resonance) device assessing insomnia and sleep outcomes.

{
    "study_type": "randomized_trial",
    "exposure": {
        "band": "ELF",
        "source": "Schumann resonance sleep device",
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": "4 weeks"
    },
    "population": "Participants with insomnia",
    "sample_size": 40,
    "outcomes": [
        "Objective sleep (polysomnography): sleep-onset latency (SOL), total sleep time (TST)",
        "Subjective sleep: sleep diaries, Pittsburgh Sleep Quality Inventory (PSQI), Epworth Sleepiness Scale (ESS), visual analogy of sleep satisfaction",
        "Quality of life: SF-36",
        "Sleep efficiency",
        "Sleep quality",
        "Daytime sleepiness",
        "Sleep satisfaction"
    ],
    "main_findings": "In the Schumann resonance (SR) sleep-device group, objective sleep measures (SOL and TST) and multiple subjective sleep measures (including SOL, TST, sleep efficiency, sleep quality, daytime sleepiness, and sleep satisfaction) significantly improved after use. In the placebo-device group, only subjective improvements (PSQI and sleep satisfaction) were observed.",
    "effect_direction": "benefit",
    "limitations": [
        "Frequency/exposure parameters for the SR device not reported in the abstract",
        "Follow-up duration limited to four weeks",
        "Sample size relatively small (n=40)"
    ],
    "evidence_strength": "moderate",
    "confidence": 0.7800000000000000266453525910037569701671600341796875,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "Schumann resonance",
        "extremely low-frequency electromagnetic field",
        "ELF-EMF",
        "insomnia",
        "sleep",
        "polysomnography",
        "PSQI",
        "ESS",
        "double-blind",
        "randomized",
        "placebo"
    ],
    "suggested_hubs": [
        {
            "slug": "sleep-and-emf",
            "weight": 0.90000000000000002220446049250313080847263336181640625,
            "reason": "Randomized double-blind trial of ELF (Schumann resonance) device assessing insomnia and sleep outcomes."
        }
    ]
}

Comments

Log in to comment.

No comments yet.